Volume 1, Issue 6, Page 6 (June 2006)
7 of 44
PREVIEW
FULL TEXT
FULL-TEXT PDF (106 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
Raloxifene is as effective as tamoxifen in preventing invasive breast cancer in postmenopausal women, according to initial results of the Study of Tamoxifen and Raloxifene (STAR) trial.
PII: S1558-0164(06)70181-X
doi:10.1016/S1558-0164(06)70181-X
© 2006 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.